![Medicinal Cannabis Draws Eyes as Oil Slides and Bond Yields Climb [FTSE AIM UK 50 INDEX]](https://cedclinic.com/wp-content/uploads/2026/06/ced-unsplash-ke6jYtwXDKA-1-150x150.jpg "Medicinal Cannabis Draws Eyes as Oil Slides and Bond Yields Climb [FTSE AIM UK 50 INDEX] 25")
Topical Cannabis for AIMSS: Medical Cannabis Evidence
Comments Off on Topical Cannabis for AIMSS: Medical Cannabis Evidence
March 25, 2026
Clinical Takeaway In this randomized trial, topical cannabis balms were evaluated for feasibility and tolerability in postmenopausal breast cancer patients experiencing joint pain and stiffness from aromatase inhibitor therapy. The study found that…
Topical Cannabis for AIMSS: Cannabinoid Clinical Trials
Comments Off on Topical Cannabis for AIMSS: Cannabinoid Clinical Trials
March 4, 2026
Topical cannabis balms for AIMSS were tested in a randomized trial for breast cancer patients experiencing joint pain from aromatase inhibitor therapy. The study assessed feasibility and safety of cannabinoid topical treatments. Results provide early…